A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda.

Trial Profile

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2015

At a glance

  • Drugs VRC-HIVADV014-00-VP (Primary) ; VRC-HIVDNA009-00-VP (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Mar 2012 Status of the trial is completed as reported by ClinicalTrials.gov. (Extension trial; NCT01549509)
    • 12 Mar 2012 Status of the trial is completed as reported by ClinicalTrials.gov. (Extension trial; NCT01549509)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top